{"success": true, "message": "Fetched question.", "data": {"showTimer": true, "showAttemptInsight": true, "playSounds": true, "dontShowCorrectAnswerImmediately": false, "_id": "615454d76e68f8da930bfecf", "type": "singleCorrect", "level": null, "category": null, "approximateTimeRequired": null, "imageBaseUrl": null, "helperText": null, "source": "NTAS1", "classes": [], "exams": ["615d76e4c52ffa3c944600e1"], "subjects": ["615d70bd9948bc1b21da2b1f"], "chapters": ["615d6fee2b295b085ab6ebc1"], "topics": [], "concepts": [], "microConcepts": [], "questionLabels": [{"title": "NTA Abhyas Paper", "value": "90", "isVisible": true}], "previousYearPapers": [], "question": {"text": "The IUPAC name of the compound &nbsp;<math> <mrow> <msub> <mtext>K</mtext> <mtext>4</mtext> </msub> <mo stretchy=\"false\">[</mo><mtext>Fe</mtext><msub> <mrow> <mrow><mo>(</mo> <mrow> <mtext>CN</mtext> </mrow> <mo>)</mo></mrow> </mrow> <mtext>6</mtext> </msub> <mo stretchy=\"false\">]</mo> </mrow> </math> &nbsp;is", "image": null}, "options": [{"id": "ehuQF", "text": "Potassium hexacyanoiron (II)", "image": null, "isCorrect": false}, {"id": "pIEZa", "text": "Potassium hexacyanoferrate (III)", "image": null, "isCorrect": false}, {"id": "z75wU", "text": "Potassium hexacyanoferrate (II)", "image": null, "isCorrect": true}, {"id": "ykLRW", "text": "Tripotassium hexacyanoiron (II)", "image": null, "isCorrect": false}], "correctValue": null, "solution": {"text": "The following rules are used while naming coordination compounds:<br /><br /><strong>(i)</strong> The cation is named first both in positively and negatively charged coordination entities.<p><strong>(ii)</strong> The ligands are named in an alphabetical order before the name of the central atom/ion.<br /><br /><strong>(iii)</strong> Names of the anionic ligands ends in-o.<br /><br /><strong>(iv)</strong> Prefixes mono, di, tri, etc. are used to indicate the number of ligands.<br /><br /><strong>(v)</strong> Oxidation state of the metal is indicated by Roman numeral. The correct name is potassium hexacyanoferrate (II).</p>", "image": null}, "videoSolution": null, "numericalLowerLimit": null, "numericalUpperLimit": null, "cpyqbSubjects": ["615f0cf69476412f48314dac", "616057040283de43c87e3e16", "61bb58281213731910ea0b71", "6160579d0283de43c87e3e1f", "61964f94a5a526011886801e", "61c055f6e8ce0dc8a5c62d34", "61a8a2cce8ce0dc8a5c62d2e", "6160577e0283de43c87e3e1c", "616057210283de43c87e3e19", "629105adee9e3ae00d63352c", "62962075e7f8e9ac4daeafd8", "629f385f263330a77be9fa7e", "629f39e4ac11b26562e0625c", "61964ff3a5a5260118868022", "64d50c263df7f4a7f3017f70", "66b79b89d4b564dfab4f94d0", "678ea9a09cc79e5f592bdc12", "67fa602f4468eb1307ceb0ae", "6807d350647479b8e869647a"], "cpyqbChapters": ["616024f4ce21b5cba7c55599", "616024f1f8b97731aafc60d6", "61c089be659d02341fe42bce", "61bb822d28d60409d131ec72", "61e7bd8115b9968c5625dc7d", "616024f22bdae059334a53e7", "616024f42aaf80dacc3609df", "61964cb73dbd768a400b833a", "616024f5e8331606aad107c5", "61964cb58daf8c64cdbf2a5e", "629109dbc567cef438b2a396", "62962117eaeca617c0b0f5e7", "629f38ff57dc3a63489b4490", "629f3a849a338a11d93a1a44", "64eb06cb3118f713ecfef0ea", "66d5853fa75f05ee8564f59a", "67921d711d5b5072da5e9b16", "67fdff3f378e1624ea7b6937", "68091fea3a10446a207fdc3e"], "cpyqbExams": ["616059d70283de43c87e3e24", "616059730283de43c87e3e22"]}}